Author:
Nagamine Takeaki,Takagi Hitoshi,Hashimoto Yoshiaki,Takayama Hisashi,Shimoda Ryuya,Nomura Naruo,Suzuki Keiji,Mori Masatomo,Nakajima Katsuyuki
Publisher
Springer Science and Business Media LLC
Subject
Biochemistry (medical),Inorganic Chemistry,Clinical Biochemistry,General Medicine,Biochemistry,Endocrinology, Diabetes and Metabolism
Reference24 articles.
1. J. H. Hoofnagele, K. D. Mullen, D. B. Jones, V. Rustgi, A. M. Di Bisceglie, M. Peters, J. G. Waggoner, et al., Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon,N. Eng. J. Med. 315, 1575–1578 (1986).
2. G. L. Davis, L. A. Balart, E. R. Schiff, K. Lindsay, H. C. Bodenheimer, Jr, R. P. Perillo, W. Carey, et al., Treatment of chronic hepatitis C with recombinant interferon alpha. A multicenter randomized, controlled trial,N. Engl. J. Med. 321, 1501–1506 (1989).
3. M. R. Jacyna, α-interferon therapy in chronic hepatitis C infection: what have we learnt so far?,Eur. J. Gastroenterol. Hepatol. 9, 703–705 (1992).
4. M. A. Houghton, A. H. Weiner, J. Han, G. Kuo, and Q. L. Choo, Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease,Hepatology 14, 381–388 (1991).
5. L. Pagliaro, A. Craxi, C. Cammaa, F. Tine, V. Di Marco, O. Lo Jacono, and P. Almasio, Interferon-alpha for chronic hepatitis C: an analysis of pretreatment clinical predictors of response,Hepatology 19, 820–828 (1994).
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献